Answers are grounded in this paper and cite their sources.
Sickle cell disease (SCD) comprises a heterogeneous group of inherited hemolytic disorders that increases the risk of maternal and perinatal complications due to chronic systemic inflammatory response, endothelial damage and vaso-occlusion. The contribution of genotypes to the severity of outcomes during pregnancy is not completely established.
No takes yet. Share an insight, caveat, or question.
Figueira et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: